Literature DB >> 7969167

Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.

S K Thukral1, G C Blain, K K Chang, S Fields.   

Abstract

We identified a minimal domain of human p53 required for the transactivation of a p53 response element in Saccharomyces cerevisiae. This domain contains the central region of p53 sufficient for specific DNA binding, which colocalizes with the region responsible for binding simian virus 40 large T antigen, 53BP1, and 53BP2. Thirty amino acid positions, including natural mutational hot spots (R175, R213, R248, R249, and R273), in the minimal DNA-binding domain were mutated by alanine substitution. Alanine substitutions at positions R213, R248, R249, D281, R282, R283, E286, and N288 affected transactivation but allowed binding to at least one of the three interacting proteins; these amino acids may be involved in amino acid-base pair contacts. Surprisingly, alanine substitution at the mutational hot spot R175 did not affect DNA binding, transactivation, or T-antigen binding, although it nearly eliminated binding to 53BP1 and 53BP2. Mutation of H168 significantly affected only T-antigen binding, and mutation of E285 affected only 53BP1 binding. Thus, we implicate specific residues of p53 in different DNA and protein interactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969167      PMCID: PMC359370          DOI: 10.1128/mcb.14.12.8315-8321.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.

Authors:  P Hinds; C Finlay; A J Levine
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  The p53 proto-oncogene can act as a suppressor of transformation.

Authors:  C A Finlay; P W Hinds; A J Levine
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

4.  A new class of yeast transcriptional activators.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

5.  p53 domains: identification and characterization of two autonomous DNA-binding regions.

Authors:  Y Wang; M Reed; P Wang; J E Stenger; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

8.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

9.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

10.  Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast.

Authors:  L Guarente
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

View more
  22 in total

1.  Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.

Authors:  C D Lopez; Y Ao; L H Rohde; T D Perez; D J O'Connor; X Lu; J M Ford; L Naumovski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.

Authors:  V S Ossovskaya; I A Mazo; M V Chernov; O B Chernova; Z Strezoska; R Kondratov; G R Stark; P M Chumakov; A V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 3.  BRCT domains: easy as one, two, three.

Authors:  Charles Chung Yun Leung; J N Mark Glover
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

4.  Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function.

Authors:  B A Wing; R A Johnson; E S Huang
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.

Authors:  Koen Schipper; Anne Paulien Drenth; Eline van der Burg; Samuel Cornelissen; Sjoerd Klarenbeek; Micha Nethe; Jos Jonkers
Journal:  Cancer Res       Date:  2020-02-14       Impact factor: 12.701

6.  Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9.

Authors:  Jacqueline L Y Chee; Suzan Saidin; David P Lane; Sai Mun Leong; Jacqueline E Noll; Paul M Neilsen; Yi Ting Phua; Hani Gabra; Tit Meng Lim
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

7.  Cyclic AMP-Rap1A signaling mediates cell surface translocation of microvascular smooth muscle α2C-adrenoceptors through the actin-binding protein filamin-2.

Authors:  Hanaa K B Motawea; Selvi C Jeyaraj; Ali H Eid; Srabani Mitra; Nicholas T Unger; Amany A E Ahmed; Nicholas A Flavahan; Maqsood A Chotani
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-17       Impact factor: 4.249

8.  Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers.

Authors:  J M Gudas; M Payton; S Thukral; E Chen; M Bass; M O Robinson; S Coats
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.

Authors:  Dean J Derbyshire; Balaku P Basu; Louise C Serpell; Woo S Joo; Takayasu Date; Kuniyoshi Iwabuchi; Aidan J Doherty
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

10.  Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence.

Authors:  Alejandro P Adam; Ajish George; Denis Schewe; Paloma Bragado; Bibiana V Iglesias; Aparna C Ranganathan; Antonis Kourtidis; Douglas S Conklin; Julio A Aguirre-Ghiso
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.